 | • レポートコード：D005-04424 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、共役ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。共役ワクチンの種類別市場規模（一価共役ワクチン、多価共役ワクチン）、用途別市場規模（小児科、成人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、GlaxoSmithKline、Pfizer、Neuron Biotech、Biological、Serum Institute of India、CSL、Bharat Biotech、Sanofi Pasteur、Merck ・地域別グローバル市場分析 2015年-2020年 ・共役ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・共役ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・共役ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・共役ワクチンの南米市場（ブラジル、アルゼンチン） ・共役ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：一価共役ワクチン、多価共役ワクチン ・用途別分析：小児科、成人 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Conjugate Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14570 million by 2025, from USD 11890 million in 2019.
The Conjugate Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Conjugate Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Conjugate Vaccines market has been segmented into
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
By Application, Conjugate Vaccines has been segmented into:
Pediatrics
Adults
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Conjugate Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Conjugate Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Conjugate Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Conjugate Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Conjugate Vaccines Market Share Analysis
Conjugate Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Conjugate Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Conjugate Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Conjugate Vaccines are:
Novartis
GlaxoSmithKline
Pfizer
Neuron Biotech
Biological
Serum Institute of India
CSL
Bharat Biotech
Sanofi Pasteur
Merck
Among other players domestic and global, Conjugate Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Conjugate Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Conjugate Vaccines, with price, sales, revenue and global market share of Conjugate Vaccines in 2018 and 2019.
Chapter 3, the Conjugate Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Conjugate Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Conjugate Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Conjugate Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Conjugate Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Conjugate Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Monovalent Conjugate Vaccines
1.2.3 Multivalent Conjugate Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Conjugate Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pediatrics
1.3.3 Adults
1.4 Overview of Global Conjugate Vaccines Market
1.4.1 Global Conjugate Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Neuron Biotech
2.4.1 Neuron Biotech Details
2.4.2 Neuron Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Neuron Biotech SWOT Analysis
2.4.4 Neuron Biotech Product and Services
2.4.5 Neuron Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biological
2.5.1 Biological Details
2.5.2 Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biological SWOT Analysis
2.5.4 Biological Product and Services
2.5.5 Biological Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Serum Institute of India SWOT Analysis
2.6.4 Serum Institute of India Product and Services
2.6.5 Serum Institute of India Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 CSL
2.7.1 CSL Details
2.7.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 CSL SWOT Analysis
2.7.4 CSL Product and Services
2.7.5 CSL Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bharat Biotech
2.8.1 Bharat Biotech Details
2.8.2 Bharat Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bharat Biotech SWOT Analysis
2.8.4 Bharat Biotech Product and Services
2.8.5 Bharat Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi Pasteur
2.9.1 Sanofi Pasteur Details
2.9.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi Pasteur SWOT Analysis
2.9.4 Sanofi Pasteur Product and Services
2.9.5 Sanofi Pasteur Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck SWOT Analysis
2.10.4 Merck Product and Services
2.10.5 Merck Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Conjugate Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Conjugate Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Conjugate Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Conjugate Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Conjugate Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Conjugate Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Conjugate Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Conjugate Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Conjugate Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Conjugate Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Conjugate Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Conjugate Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Conjugate Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Conjugate Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Conjugate Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Conjugate Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Conjugate Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Conjugate Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Conjugate Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Conjugate Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Conjugate Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Conjugate Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Conjugate Vaccines Sales and Growth Rate (2015-2020)
6.4 France Conjugate Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Conjugate Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Conjugate Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Conjugate Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Conjugate Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Conjugate Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Conjugate Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Conjugate Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Conjugate Vaccines Sales and Growth Rate (2015-2020)
7.5 India Conjugate Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Conjugate Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Conjugate Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Conjugate Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Conjugate Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Conjugate Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Conjugate Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Conjugate Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Conjugate Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Conjugate Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Conjugate Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Conjugate Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Conjugate Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Conjugate Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Conjugate Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Conjugate Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Conjugate Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Conjugate Vaccines Price by Type (2015-2020)
11 Global Conjugate Vaccines Market Segment by Application
11.1 Global Conjugate Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Conjugate Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Conjugate Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Conjugate Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Conjugate Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Conjugate Vaccines Market Forecast (2021-2025)
12.2.2 Europe Conjugate Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Conjugate Vaccines Market Forecast (2021-2025)
12.2.4 South America Conjugate Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Conjugate Vaccines Market Forecast (2021-2025)
12.3 Conjugate Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Conjugate Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Conjugate Vaccines Market Share Forecast by Type (2021-2025)
12.4 Conjugate Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Conjugate Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Conjugate Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Conjugate Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Conjugate Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Conjugate Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Conjugate Vaccines Major Business
Table 9. Novartis Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Conjugate Vaccines Product and Services
Table 12. Novartis Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Conjugate Vaccines Major Business
Table 15. GlaxoSmithKline Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 16. GlaxoSmithKline SWOT Analysis
Table 17. GlaxoSmithKline Conjugate Vaccines Product and Services
Table 18. GlaxoSmithKline Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Conjugate Vaccines Major Business
Table 21. Pfizer Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Conjugate Vaccines Product and Services
Table 24. Pfizer Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Neuron Biotech Basic Information, Manufacturing Base and Competitors
Table 26. Neuron Biotech Conjugate Vaccines Major Business
Table 27. Neuron Biotech Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 28. Neuron Biotech SWOT Analysis
Table 29. Neuron Biotech Conjugate Vaccines Product and Services
Table 30. Neuron Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Biological Basic Information, Manufacturing Base and Competitors
Table 32. Biological Conjugate Vaccines Major Business
Table 33. Biological Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 34. Biological SWOT Analysis
Table 35. Biological Conjugate Vaccines Product and Services
Table 36. Biological Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 38. Serum Institute of India Conjugate Vaccines Major Business
Table 39. Serum Institute of India Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 40. Serum Institute of India SWOT Analysis
Table 41. Serum Institute of India Conjugate Vaccines Product and Services
Table 42. Serum Institute of India Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. CSL Basic Information, Manufacturing Base and Competitors
Table 44. CSL Conjugate Vaccines Major Business
Table 45. CSL Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 46. CSL SWOT Analysis
Table 47. CSL Conjugate Vaccines Product and Services
Table 48. CSL Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 50. Bharat Biotech Conjugate Vaccines Major Business
Table 51. Bharat Biotech Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 52. Bharat Biotech SWOT Analysis
Table 53. Bharat Biotech Conjugate Vaccines Product and Services
Table 54. Bharat Biotech Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 56. Sanofi Pasteur Conjugate Vaccines Major Business
Table 57. Sanofi Pasteur Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 58. Sanofi Pasteur SWOT Analysis
Table 59. Sanofi Pasteur Conjugate Vaccines Product and Services
Table 60. Sanofi Pasteur Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Conjugate Vaccines Major Business
Table 63. Merck Conjugate Vaccines Total Revenue (USD Million) (2017-2018)
Table 64. Merck SWOT Analysis
Table 65. Merck Conjugate Vaccines Product and Services
Table 66. Merck Conjugate Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Conjugate Vaccines Sales by Manufacturer (2018-2019) (K Doses)
Table 68. Global Conjugate Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Conjugate Vaccines Sales by Regions (2015-2020) (K Doses)
Table 70. Global Conjugate Vaccines Sales Market Share by Regions (2015-2020)
Table 71. Global Conjugate Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Conjugate Vaccines Sales by Countries (2015-2020) (K Doses)
Table 73. North America Conjugate Vaccines Sales Market Share by Countries (2015-2020)
Table 74. North America Conjugate Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Conjugate Vaccines Revenue Market Share by Countries (2015-2020)
Table 76. Europe Conjugate Vaccines Sales by Countries (2015-2020) (K Doses)
Table 77. Europe Conjugate Vaccines Sales Market Share by Countries (2015-2020)
Table 78. Europe Conjugate Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Conjugate Vaccines Sales by Regions (2015-2020) (K Doses)
Table 80. Asia-Pacific Conjugate Vaccines Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Conjugate Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Conjugate Vaccines Sales by Countries (2015-2020) (K Doses)
Table 83. South America Conjugate Vaccines Sales Market Share by Countries (2015-2020)
Table 84. South America Conjugate Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Conjugate Vaccines Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Conjugate Vaccines Sales by Countries (2015-2020) (K Doses)
Table 87. Middle East & Africa Conjugate Vaccines Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Conjugate Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Conjugate Vaccines Revenue Market Share by Countries (2015-2020)
Table 90. Global Conjugate Vaccines Sales by Type (2015-2020) (K Doses)
Table 91. Global Conjugate Vaccines Sales Share by Type (2015-2020)
Table 92. Global Conjugate Vaccines Revenue by Type (2015-2020) (USD Million)
Table 93. Global Conjugate Vaccines Revenue Share by Type (2015-2020)
Table 94. Global Conjugate Vaccines Sales by Application (2015-2020) (K Doses)
Table 95. Global Conjugate Vaccines Sales Share by Application (2015-2020)
Table 96. Global Conjugate Vaccines Sales Forecast by Regions (2021-2025) (K Doses)
Table 97. Global Conjugate Vaccines Market Share Forecast by Regions (2021-2025)
Table 98. Global Conjugate Vaccines Sales Forecast by Type (2021-2025) (K Doses)
Table 99. Global Conjugate Vaccines Market Share Forecast by Type (2021-2025)
Table 100. Global Conjugate Vaccines Sales Forecast by Application (2021-2025)
Table 101. Global Conjugate Vaccines Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Conjugate Vaccines Picture
Figure 2. Global Sales Market Share of Conjugate Vaccines by Type in 2019
Figure 3. Monovalent Conjugate Vaccines Picture
Figure 4. Multivalent Conjugate Vaccines Picture
Figure 5. Conjugate Vaccines Sales Market Share by Application in 2018
Figure 6. Pediatrics Picture
Figure 7. Adults Picture
Figure 8. Global Conjugate Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Conjugate Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Conjugate Vaccines Sales Market Share by Manufacturer in 2019
Figure 29. Global Conjugate Vaccines Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Conjugate Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Conjugate Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 34. Global Conjugate Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Conjugate Vaccines Revenue Market Share by Regions (2015-2020)
Figure 36. Global Conjugate Vaccines Revenue Market Share by Regions in 2018
Figure 37. North America Conjugate Vaccines Sales and Growth Rate (2015-2020)
Figure 38. Europe Conjugate Vaccines Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Conjugate Vaccines Sales and Growth Rate (2015-2020)
Figure 40. South America Conjugate Vaccines Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Conjugate Vaccines Sales and Growth Rate (2015-2020)
Figure 42. North America Conjugate Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Conjugate Vaccines Sales Market Share by Countries (2015-2020)
Figure 44. North America Conjugate Vaccines Sales Market Share by Countries in 2018
Figure 45. North America Conjugate Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Conjugate Vaccines Revenue Market Share by Countries in 2018
Figure 47. United States Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 48. Canada Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Mexico Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Europe Conjugate Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Conjugate Vaccines Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Conjugate Vaccines Revenue Market Share by Countries in 2019
Figure 53. Germany Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. UK Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. France Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. Russia Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Asia-Pacific Conjugate Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Conjugate Vaccines Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Conjugate Vaccines Revenue Market Share by Regions 2019
Figure 61. China Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Japan Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Korea Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. India Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Southeast Asia Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. South America Conjugate Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Conjugate Vaccines Sales Market Share by Countries in 2019
Figure 68. South America Conjugate Vaccines Revenue Market Share by Countries in 2019
Figure 69. Brazil Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. Argentina Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Middle East and Africa Conjugate Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Conjugate Vaccines Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Conjugate Vaccines Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Conjugate Vaccines Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 76. Egypt Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Turkey Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. South Africa Conjugate Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Global Conjugate Vaccines Sales and Growth Rate (2021-2025) (K Doses)
Figure 80. Global Conjugate Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Conjugate Vaccines Market Forecast (2021-2025) (K Doses)
Figure 82. Europe Sales Conjugate Vaccines Market Forecast (2021-2025) (K Doses)
Figure 83. Asia-Pacific Sales Conjugate Vaccines Market Forecast (2021-2025) (K Doses)
Figure 84. South America Sales Conjugate Vaccines Market Forecast (2021-2025) (K Doses)
Figure 85. Middle East & Africa Sales Conjugate Vaccines Market Forecast (2021-2025) (K Doses)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
コンパニオンアニマルス用専門薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Companion Animal Specialty Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Companion An…- 生物製剤及びバイオシミラーの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Biologics and Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 279640 million by 2025, from USD 236240 million in 2019. The Bi…
- 小児科用抗てんかん薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-epileptic Drugs for Pediatrics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 839.2 million by 2025, from USD 709.5 million in 2019. The An…
- 水痘ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chickenpox Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chickenpox Vaccine market …
- クラリタインの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Clarityne market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Clarityne market report provides a …